LINE BODY Safe & Easy 55 Soft Type is a cross-linked hyaluronic acid body filler in a 55 mL pre-filled syringe, formulated at 20 mg/mL. The Soft Type designation indicates a pliable, lower-resistance gel designed for smooth, natural-looking volumization in large body areas such as the breasts, hips, and buttocks. Its softer texture allows for easy injection and smooth distribution across wide areas. For use by licensed medical professionals only.

Both Soft and Hard Types share the same 20 mg/mL HA concentration, 55 mL syringe format, patented stabilization technology, BDDE level, and 36-month shelf life. The difference is gel firmness: the Soft Type has lower cross-linking density, giving a more pliable, easier-to-inject gel that distributes smoothly and integrates naturally into surrounding tissue. The Hard Type has a firmer, more cohesive gel with stronger lifting force and structural projection. Clinically: Soft Type is chosen when natural, harmonious enhancement and smooth distribution are the priority; Hard Type is preferred when firm projection and defined structural correction are required.

Yes. Due to its softer, more pliable texture, LINE BODY Soft Type is also used by practitioners for large-area skin revitalization — including the face, neck, and décolleté — where HA hydration, structure support, and tissue quality improvement are the goals alongside volume. The softer gel is better suited to superficial or semi-deep planes for these applications compared to the Hard Type. Technique, depth, and suitability are always at the practitioner’s discretion.

Results are expected to last up to 12 months. Duration varies between patients depending on individual metabolic rate, treatment area, volume injected, injection depth, and post-treatment care. The patented HA stabilization technique ensures slow, uniform decomposition. Areas with higher movement or pressure (e.g. calves) may break down product faster than lower-movement areas. Touch-up sessions can maintain results.

BDDE is the chemical cross-linker used to stabilize HA gels. Residual unlinked BDDE is associated with adverse inflammatory reactions. For body fillers specifically, the volumes injected are significantly larger than for facial fillers — often 20 mL to 55 mL per session vs 1–2 mL for facial procedures. This means total BDDE exposure is proportionally higher, making low residue levels more clinically significant. LINE BODY Safe & Easy 55 Soft Type confirms BDDE below 0.2 ppm, which is ten times lower than the FDA guideline threshold of 2 ppm.

LINE BODY Safe & Easy 55 Soft Type must be administered exclusively by licensed medical professionals in a clinical setting. Self-administration is strictly prohibited and may result in serious adverse events including vascular occlusion, embolism, or necrosis. Contraindicated in patients with known hypersensitivity to hyaluronic acid or any product component. Injection into vascular structures is contraindicated. The treating practitioner is responsible for patient assessment, injection depth, anatomical plane, volume, and post-treatment care. Patients should avoid intense physical activity, heat exposure, and pressure on the treated area in the immediate post-procedure period.